On Tuesday, Vir Biotechnology Inc (NASDAQ: VIR) was 1.94% up from the session before settling in for the closing price of $4.64. A 52-week range for VIR has been $4.32 – $14.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 423.44% over the last five years. When this article was written, the company’s average yearly earnings per share was at 16.37%. With a float of $89.14 million, this company’s outstanding shares have now reached $138.06 million.
The firm has a total of 408 workers. Let’s measure their productivity. In terms of profitability, gross margin is 68.7%, operating margin of -3081.35%, and the pretax margin is -2950.89%.
Vir Biotechnology Inc (VIR) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vir Biotechnology Inc stocks. The insider ownership of Vir Biotechnology Inc is 35.52%, while institutional ownership is 54.76%. The most recent insider transaction that took place on Apr 03 ’25, was worth 474,239. In this transaction Chief Executive Officer of this company sold 79,712 shares at a rate of $5.95, taking the stock ownership to the 769,505 shares. Before that another transaction happened on Apr 03 ’25, when Company’s Officer and Director proposed sale 79,712 for $5.95, making the entire transaction worth $474,239.
Vir Biotechnology Inc (VIR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.74 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.19% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
You can see what Vir Biotechnology Inc (VIR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 31.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.22, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -3.08 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Analysing the last 5-days average volume posted by the [Vir Biotechnology Inc, VIR], we can find that recorded value of 1.6 million was lower than the volume posted last year of 1.81 million. As of the previous 9 days, the stock’s Stochastic %D was 24.01%. Additionally, its Average True Range was 0.37.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 4.05%, which indicates a significant decrease from 20.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.96% in the past 14 days, which was lower than the 98.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.98, while its 200-day Moving Average is $7.84. Now, the first resistance to watch is $4.88. This is followed by the second major resistance level at $5.02. The third major resistance level sits at $5.20. If the price goes on to break the first support level at $4.55, it is likely to go to the next support level at $4.37. Now, if the price goes above the second support level, the third support stands at $4.23.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
There are 138,238K outstanding shares of the company, which has a market capitalization of 653.86 million. As of now, sales total 74,210 K while income totals -521,960 K. Its latest quarter income was 3,030 K while its last quarter net income were -120,970 K.
